Simplex Trading
CATX icon

Simplex Trading’s Perspective Therapeutics CATX Stock Holding History

Simplex Trading’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$177K Buy
+42,486
New +$179K ﹤0.01% 4435

Other funds holding CATX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Simplex Trading's CATX Position: Q1 2026 in Review

Simplex Trading opened a new position in Perspective Therapeutics (CATX) in Q1 2026: 42,486 shares worth $177K. The stake represents ﹤0.01% of the portfolio and ranks #4435 among its holdings.

138 funds tracked by Wall St. Rank hold CATX as of Q1 2026.

  • Simplex Trading held 42,486 shares of Perspective Therapeutics worth $177K as of Q1 2026.
  • Perspective Therapeutics was a new Simplex Trading position in Q1 2026.
  • Perspective Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4435 holding.
  • 138 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.